ACER3 and metabolic dysfunction-associated steatohepatitis: In silico analyses using a dataset of gene expression in liver from NAFLD study by Markus Ahrens et al. 32 revealed that among the five ceramidase genes, only ACER3 mRNA levels were significantly upregulated in NASH liver compared to healthy liver and NAFL liver (Fig. 1a).